01 September 2003
Role of mast cells,adenosine receptors and oxidized plasma proteins in chronic inflammation
Joanna Renke, Maria Korzon, Stefan Popadiuk, Barbara Gumkowska-Kamińska, Małgorzata Szumera, Michał WoźniakMed Sci Monit 2003; 9(4): 86-88 :: ID: 428657
Abstract
Mast cells have been recently found a very interesting point of investigation, due to their possible role in sustaining the chronic inflammation, being a histological hallmark for some pathologies and, through adenosine receptors, a receptoral handle for some new drugs. It is well known, that mast cells play a central role in immediate allergic reactions mediated by immunoglobulin E. It has been reported, that mast cells generate intracellular reactive oxygen species (ROS) in response to stimulation with divergent physiologically relevant stimulants. The intensification of ROS production may be measured by the level of carbonyl groups, as a marker of protein peroxidation. However, the role of mast cells in other than asthma diseases with chronic inflammation needs further investigation. It was found out, that mast cells distribution in colonic mucosa may serve as a help in differentiation between inflammatory bowel disease and collagenous colitis. Moreover, its accumulation in focal active gastritis was confirmed in patients with Crohn’s disease. Though, an important role in regulation of inflammatory process is reserved for adenosine receptors present on mastocytes. The activation of mast cells through the adenosine receptor is connected with Il-8 release, which stimulate the migration of leukocytes and oxidation reactions. The antiasthmatic drug, enprofylline, is the first known selective, though not potent A 2B receptor anthagonist that may has its application in asthma. The detection of mast cells in tissues should not be limited only to the simple histologic examination, because it cannot adequately reflect their function and state of activation.
Keywords: Mast Cells, tryptase, adenosine receptors, protein peroxidation
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
26 Feb 2024 : Clinical Research
Predictive Value of Combined HbA1c and Neutrophil-to-Lymphocyte Ratio for Diabetic Peripheral Neuropathy in...Med Sci Monit In Press; DOI: 10.12659/MSM.942509
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952